litlas
ログインアカウント作成

U. Gatzemeier

1993–2023 年に発表

36
論文数
18,948
被引用数
36
h 指数
36
i10 指数

被引用数

U. Gatzemeier の年別被引用数1992 年: 被引用 1 件1994 年: 被引用 3 件1995 年: 被引用 3 件1996 年: 被引用 4 件1997 年: 被引用 10 件1998 年: 被引用 8 件1999 年: 被引用 10 件2000 年: 被引用 19 件2001 年: 被引用 28 件2002 年: 被引用 47 件2003 年: 被引用 62 件2004 年: 被引用 91 件2005 年: 被引用 182 件2006 年: 被引用 166 件2007 年: 被引用 166 件2008 年: 被引用 136 件2009 年: 被引用 231 件2010 年: 被引用 226 件2011 年: 被引用 196 件2012 年: 被引用 149 件2013 年: 被引用 205 件2014 年: 被引用 134 件2015 年: 被引用 140 件2016 年: 被引用 111 件2017 年: 被引用 94 件2018 年: 被引用 85 件2019 年: 被引用 256 件2020 年: 被引用 253 件2021 年: 被引用 223 件2022 年: 被引用 116 件2023 年: 被引用 83 件2024 年: 被引用 123 件2025 年: 被引用 46 件2026 年: 被引用 1 件1993 年は被引用が無いため表示していません

引用元

国・地域

この著者を引用した国・地域の世界地図アメリカ合衆国: 引用元論文 1,352 件、この内訳の 27.8%イタリア: 引用元論文 351 件、この内訳の 7.2%中国: 引用元論文 307 件、この内訳の 6.3%イギリス: 引用元論文 304 件、この内訳の 6.3%ドイツ: 引用元論文 241 件、この内訳の 5%日本: 引用元論文 230 件、この内訳の 4.7%フランス: 引用元論文 193 件、この内訳の 4%カナダ: 引用元論文 179 件、この内訳の 3.7%オーストラリア: 引用元論文 174 件、この内訳の 3.6%スペイン: 引用元論文 170 件、この内訳の 3.5%オランダ: 引用元論文 155 件、この内訳の 3.2%スイス: 引用元論文 133 件、この内訳の 2.7%
0%27.8%その他 22%

機関

分野

  • Medicine78.2%
  • Biochemistry, Genetics and Molecular Biology15.1%
  • Immunology and Microbiology1.7%
  • Materials Science1.4%
  • Chemistry0.7%
  • Mathematics0.6%
  • その他2.3%

トピック

  • Lung Cancer Treatments and Mutations14.7%
  • Lung Cancer Research Studies7.3%
  • Lung Cancer Diagnosis and Treatment6.1%
  • Occupational and environmental lung diseases5.7%
  • Cancer Immunotherapy and Biomarkers4%
  • Pleural and Pulmonary Diseases3.7%
  • その他58.5%

共著者

全論文

検索で開く
  1. Phase III Study of Pemetrexed in Combination With Cisplatin Versus Cisplatin Alone in Patients With Malignant Pleural Mesothelioma

    著者: Nicholas J. Vogelzang, James J. Rusthoven, James T. Symanowski, Claude Denham, E. Kaukel, Pierre Ruffiè, U. Gatzemeier, Michael Boyer, Salih Emri, Christian Manegold, Clet Niyikiza, Paolo Paoletti - Journal of Clinical Oncology 2003 被引用: 3,063

  2. Phase III Study Comparing Cisplatin Plus Gemcitabine With Cisplatin Plus Pemetrexed in Chemotherapy-Naive Patients With Advanced-Stage Non–Small-Cell Lung Cancer

    著者: Giorgio V. Scagliotti, Purvish Parikh, Joachim von Pawel, Bonne Biesma, Johan Vansteenkiste, Christian Manegold, Piotr Serwatowski, U. Gatzemeier, Raghunadharao Digumarti, Mauro Zukin, Jin S. Lee, Anders Mellemgaard, Keunchil Park, Shehkar Patil, Janusz Rolski, Tuncay Göksel, Filippo de Marinis, Lorinda Simms, Katherine P. Sugarman, David R. Gandara - Journal of Clinical Oncology 2008 被引用: 3,221

  3. Randomized Phase III Trial of Pemetrexed Versus Docetaxel in Patients With Non–Small-Cell Lung Cancer Previously Treated With Chemotherapy

    著者: Nasser H. Hanna, Frances A. Shepherd, Frank V. Fossella, Jose R. Pereira, Filippo de Marinis, Joachim von Pawel, U. Gatzemeier, Thomas Chang Yao Tsao, Miklos Pless, Thomas Müller, Hong-Liang Lim, Christopher E. Desch, Klára Szondy, Radj Gervais, Shaharyar, Christian Manegold, Sofia Paul, Paolo Paoletti, Lawrence Einhorn, Paul A. Bunn - Journal of Clinical Oncology 2004 被引用: 2,433

  4. Gefitinib in Combination With Gemcitabine and Cisplatin in Advanced Non–Small-Cell Lung Cancer: A Phase III Trial—INTACT 1

    著者: Giuseppe Giaccone, Roy S. Herbst, Christian Manegold, Giorgio V. Scagliotti, Rafael Rosell, Vincent A. Miller, Ronald B. Natale, Joan H. Schiller, Joachim von Pawel, A Płużańska, U. Gatzemeier, John Grous, Judith Ochs, Steven D. Averbuch, Michael Wolf, Pamela Rennie, Abderrahim Fandi, David H. Johnson - Journal of Clinical Oncology 2004 被引用: 1,720

  5. Randomized phase II trial of gemcitabine–cisplatin with or without trastuzumab in HER2-positive non-small-cell lung cancer

    著者: U. Gatzemeier, G. Groth, Charles Butts, Nico van Zandwijk, Frances A. Shepherd, Andrea Ardizzoni, Claire Barton, Parviz Ghahramani, Vera Hirsh - Annals of Oncology 2003 被引用: 384

  6. Cetuximab plus chemotherapy in patients with advanced non-small-cell lung cancer (FLEX): an open-label randomised phase III trial

    著者: Robert Pirker, Jose R. Pereira, Aleksandra Szczęsna, Joachim von Pawel, Maciej Krzakowski, Rodryg Ramlau, Ihor Vynnychenko, Keunchil Park, Chih-Teng Yu, Valentyn Ganul, Jae-Kyung Roh, Emilio Bajetta, Kenneth J. O’Byrne, Filippo de Marinis, Wilfried Eberhardt, Thomas Goddemeier, Michael Emig, U. Gatzemeier - The Lancet 2009 被引用: 1,355

  7. Randomized Phase III Study of Matrix Metalloproteinase Inhibitor BMS-275291 in Combination With Paclitaxel and Carboplatin in Advanced Non-Small-Cell Lung Cancer: National Cancer Institute of Canada-Clinical Trials Group Study BR.18

    著者: Natasha B. Leighl, Luis Paz‐Ares, Jean-Yves Douillard, Christian Peschel, Andrew Arnold, A Depierre, Armando Santoro, Daniel Betticher, U. Gatzemeier, Jacek Jassem, Jeffrey Crawford, Dongsheng Tu, Andrea Bezjak, Jeffrey S. Humphrey, Maurizio Voi, Susan Galbraith, K. Hann, Lesley Seymour, Frances A. Shepherd - Journal of Clinical Oncology 2005 被引用: 178

  8. Phase III Study of Erlotinib in Combination With Cisplatin and Gemcitabine in Advanced Non–Small-Cell Lung Cancer: The Tarceva Lung Cancer Investigation Trial

    著者: U. Gatzemeier, A Płużańska, Aleksandra Szczęsna, E. Kaukel, Jaromı́r Roubec, Flavio De Rosa, Janusz Milanowski, Hanna Karnicka-Mlodkowski, Miloš Pešek, Piotr Serwatowski, Rodryg Ramlau, Terezie Janaskova, Johan Vansteenkiste, János Strausz, Georgy M. Manikhas, Joachim von Pawel - Journal of Clinical Oncology 2007 被引用: 880

  9. First-cycle rash and survival in patients with advanced non-small-cell lung cancer receiving cetuximab in combination with first-line chemotherapy: a subgroup analysis of data from the FLEX phase 3 study

    著者: U. Gatzemeier, Joachim von Pawel, Ihor Vynnychenko, Petr Zatloukal, Filippo de Marinis, Wilfried Eberhardt, Luis Paz‐Ares, Karl-Maria Schumacher, Thomas Goddemeier, Kenneth J. O’Byrne, Robert Pirker - The Lancet Oncology 2010 被引用: 117

  10. Phase II Comparator Study of Oral Versus Intravenous Topotecan in Patients With Chemosensitive Small-Cell Lung Cancer

    著者: Joachim von Pawel, U. Gatzemeier, Jean-Louis Pujol, L. Moreau, Stephan Bildat, Malcolm Ranson, Gary Richardson, Claus Steppert, Alain Rivière, Ina Camlett, Stephen Lane, Graham Ross - Journal of Clinical Oncology 2001 被引用: 233

  11. Adenovirus-Mediated Wild-Type p53 Gene Transfer in Patients Receiving Chemotherapy for Advanced Non–Small-Cell Lung Cancer: Results of a Multicenter Phase II Study

    著者: Martin Schüler, Richard Herrmann, Jacques De Grève, A. Keith Stewart, U. Gatzemeier, David J. Stewart, Leslie Rodgers Laufman, Richard J. Gralla, Jürgen Kuball, Roland Buhl, Claus Peter Heußel, Friedrich Kommoss, André P. Perruchoud, Frances A. Shepherd, Mary Ann Fritz, Jo Ann Horowitz, Christoph Huber, Christoph Rochlitz - Journal of Clinical Oncology 2001 被引用: 210

  12. Randomized Phase III Trial of Pemetrexed Versus Docetaxel in Patients With Non-Small-Cell Lung Cancer Previously Treated With Chemotherapy

    著者: Nasser H. Hanna, Frances A. Shepherd, Frank V. Fossella, Jose R. Pereira, Filippo de Marinis, Joachim von Pawel, U. Gatzemeier, Thomas Chang Yao Tsao, Miklos Pless, Thomas Müller, Hong-Liang Lim, Christopher E. Desch, Klára Szondy, Radj Gervais, Shaharyar, Christian Manegold, Sofia Paul, Paolo Paoletti, Lawrence Einhorn, Paul A. Bunn - Journal of Clinical Oncology 2023 被引用: 167

  13. Second-line (post-study) chemotherapy received by patients treated in the phase III trial of pemetrexed plus cisplatin versus cisplatin alone in malignant pleural mesothelioma

    著者: C. Manegold, James T. Symanowski, U. Gatzemeier, Martin Reck, Joachim von Pawel, C. Kortsik, K. Nackaerts, P. Lianes, Nicholas J. Vogelzang - Annals of Oncology 2005 被引用: 163

  14. Results of a phase III trial of erlotinib (OSI-774) combined with cisplatin and gemcitabine (GC) chemotherapy in advanced non-small cell lung cancer (NSCLC)

    著者: U. Gatzemeier, A Płużańska, A. Szczęsna, E. Kaukel, Jaromı́r Roubec, U. Brennscheidt, F. De Rosa, Beatrice U. Mueller, Joachim von Pawel - Journal of Clinical Oncology 2004 被引用: 300

  15. Tirapazamine Plus Cisplatin Versus Cisplatin in Advanced Non–Small-Cell Lung Cancer: A Report of the International CATAPULT I Study Group

    著者: Joachim von Pawel, Reinhard von Roemeling, U. Gatzemeier, Michael Boyer, Lars Ove Elisson, Peter Clark, Denis Talbot, A Rey, Thomas W. Butler, Vera Hirsh, Ian Olver, Bengt Bergman, Joseph Ayoub, Gary Richardson, David J. Dunlop, Anthony G. Arcenas, Robert Vescio, Jean Viallet, Joseph Treat - Journal of Clinical Oncology 2000 被引用: 286

  16. Phase III trial comparing paclitaxel poliglumex vs docetaxel in the second-line treatment of non-small-cell lung cancer

    著者: Luis Paz‐Ares, Helen J. Ross, Mary O’Brien, A. Riviére, U. Gatzemeier, Joachim von Pawel, E. Kaukel, L Freitag, W. Digel, Helge Bischoff, Rosario García‐Campelo, Nicholas Iannotti, Pavel Reiterer, Isabel Bover, J Prendiville, Amy J. Eisenfeld, F. B. Oldham, B. Bandstra, Jack W. Singer, Philip Bonomi - British Journal of Cancer 2008 被引用: 167

  17. A phase II double-blind study to investigate efficacy and safety of two doses of the triple angiokinase inhibitor BIBF 1120 in patients with relapsed advanced non-small-cell lung cancer

    著者: Martin Reck, R. Kaiser, C. Eschbach, Martin Štefanič, James Love, U. Gatzemeier, Peter Stopfer, Joachim von Pawel - Annals of Oncology 2011 被引用: 149

  18. Phase III Trial Comparing Carboplatin, Paclitaxel, and Bexarotene With Carboplatin and Paclitaxel in Chemotherapy-Naïve Patients With Advanced or Metastatic Non–Small-Cell Lung Cancer: SPIRIT II

    著者: George R. Blumenschein, Fadlo R. Khuri, Joachim von Pawel, U. Gatzemeier, Wilson H. Miller, Robert M. Jotte, J. Le Treut, Show-Li Sun, Jinkun K. Zhang, Zofia E. Dziewanowska, A. Negro‐Vilar - Journal of Clinical Oncology 2008 被引用: 96

  19. Phase III Trial of Gemcitabine Plus Cisplatin Versus Cisplatin Alone in Patients With Locally Advanced or Metastatic Non–Small-Cell Lung Cancer

    著者: Alan B. Sandler, John Nemunaitis, Claude Denham, Joachim von Pawel, Yvon Cormier, U. Gatzemeier, K. Mattson, C. Manegold, Martin Palmer, Anne Gregor, Binh Thanh Nguyen, Clet Niyikiza, L H Einhorn - Journal of Clinical Oncology 2000 被引用: 719

  20. Recombinant granulocyte colony stimulating factor reduces the infectious complications of cytotoxic chemotherapy

    著者: V. Trillet-Lenoir, J. Green, C. Manegold, Joachim von Pawel, U. Gatzemeier, B Lebeau, A Depierre, Peter Johnson, Genevieve Decoster, Dianne Tomita, C. Ewen - European Journal of Cancer 1993 被引用: 545

  21. Phase II Study of Pemetrexed With and Without Folic Acid and Vitamin B12 as Front-Line Therapy in Malignant Pleural Mesothelioma

    著者: Giorgio V. Scagliotti, Dong-M. Shin, Hedy L. Kindler, Michael J. Vasconcelles, U. Keppler, Christian Manegold, Howard A. Burris, U. Gatzemeier, J. Blatter, James T. Symanowski, James J. Rusthoven - Journal of Clinical Oncology 2003 被引用: 255

  22. Phase II, Multicenter, Uncontrolled Trial of Single-Agent Sorafenib in Patients With Relapsed or Refractory, Advanced Non–Small-Cell Lung Cancer

    著者: George R. Blumenschein, U. Gatzemeier, Frank V. Fossella, David J. Stewart, Lisa Cupit, Frank Cihon, James J. O’Leary, Martin Reck - Journal of Clinical Oncology 2009 被引用: 204

  23. A Phase II Pharmacodynamic Study of Erlotinib in Patients with Advanced Non–Small Cell Lung Cancer Previously Treated with Platinum-Based Chemotherapy

    著者: Enriqueta Felip, Federico Rojo, Martin Reck, Astrid Heller, Barbara Klughammer, Gemma Laguillo Sala, S. Cedrés, Sergio Peralta, Heiko Maacke, Dorothee Foernzler, Marta Parera, Joachim Möcks, Cristina Saura, U. Gatzemeier, José Baselga - Clinical Cancer Research 2008 被引用: 77

  24. Phase III randomised trial comparing paclitaxel/carboplatin with paclitaxel/cisplatin in patients with advanced non-small-cell lung cancer: a cooperative multinational trial

    著者: Rafael Rosell, U. Gatzemeier, Daniel Betticher, U. Keppler, H.-N. Macha, Robert Pirker, Pascaline Berthet, J.L. Breau, P. Lianes, M. Nicholson, Andrea Ardizzoni, A. Chemaissani, Jan Bogaerts, G. Gallant - Annals of Oncology 2002 被引用: 302